Boardroom Alpha
Start trial
S-1 primary document
LEXX · Registration Statement (Form S-1) · Filed October 14, 2025

Lexaria Bioscience Corp — S-1 exhibit

lxrp_ex107.htm
Lexaria Bioscience Corp on Boardroom Alpha
lxrp_ex107.htm

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

S-1

(Form Type)

 

Lexaria Bioscience Corp.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

 

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee(1)

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock underlying warrants with an exercise price of $1.37 per share

457(c)

2,666,667

(2)

$2,191,866.94

$0.00015310

$335.58

-

-

-

-

Equity

Common Stock underlying warrants with an exercise price of $1.875 per share

457(c)

93,333

(3)

$76,715.06

$0.00015310

$11.75

-

-

-

-

Fees Previously Paid

-

-

-

-

-

-

-

-

Carry Forward Securities

Carry Forward Securities

-

Total Offering Amounts

$347.33

Total Fees Previously Paid

-

Total Fee Offsets

-

Net Fee Due

$347.33

 

(1)

Rounded up to the nearest cent.

(2)

The price per share used to obtain the maximum offering amount of such common stock for the purposes of calculating the registration fee was $0.82195, the average of the high and low trading prices of the Company’s common stock as reported on the Nasdaq Capital Market on October 7, 2025.

(3)

The price per share used to obtain the maximum offering amount of such common stock for the purposes of calculating the registration fee was $0.82195, the average of the high and low trading prices of the Company’s Common Stock as reported on the Nasdaq Capital Market on October 7, 2025.

 

Table 2: Fee Offset Claims and Sources

 

N/A

 

Table 3: Combined Prospectuses

 

N/A

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer